Details for Patent: 10,022,509
Which drugs does patent 10,022,509 protect, and when does it expire?
Patent 10,022,509 protects QVAR REDIHALER and is included in one NDA.
This patent has one hundred and ninety-two patent family members in twenty-four countries.
Summary for Patent: 10,022,509
| Title: | Dose counter for inhaler having a bore and shaft arrangement |
| Abstract: | A dose counter for an inhaler, the dose counter having a display tape arranged to be incrementally driven from a tape stock bobbin onto an incremental tape take-up drive shaft, the bobbin having an internal bore supported by and for rotation about a support shaft, at least one of the bore and support shaft having a protrusion which is resiliently biased into frictional engagement with the other of the bore and support shaft with longitudinally extending mutual frictional interaction. |
| Inventor(s): | Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg |
| Assignee: | Teva Pharmaceuticals Ireland , Ivax Pharmaceuticals Ireland , Norton Waterford Ltd |
| Application Number: | US15/269,102 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,022,509 |
|
Patent Claim Types: see list of patent claims | Delivery; |
Drugs Protected by US Patent 10,022,509
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,022,509
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011254958 | ⤷ Start Trial | |||
| Brazil | 112012029106 | ⤷ Start Trial | |||
| Canada | 2799625 | ⤷ Start Trial | |||
| Canada | 2887315 | ⤷ Start Trial | |||
| Canada | 2936362 | ⤷ Start Trial | |||
| Canada | 3019694 | ⤷ Start Trial | |||
| Canada | 3111537 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
